Integrated Diagnostics Holdings plc (LON:IDHC)

London flag London · Delayed Price · Currency is GBP · Price in USD
0.600
0.00 (0.00%)
Mar 6, 2026, 4:29 PM GMT
86.05%
Market Cap 256.14M
Revenue (ttm) 114.96M
Net Income (ttm) 20.48M
Shares Out 581.33M
EPS (ttm) 0.04
PE Ratio 12.46
Forward PE 13.55
Dividend 0.01 (2.88%)
Ex-Dividend Date Sep 11, 2025
Volume 47,588
Average Volume 158,213
Open 0.600
Previous Close 0.600
Day's Range 0.575 - 0.600
52-Week Range 0.305 - 0.830
Beta 0.28
RSI 36.47
Earnings Date Apr 8, 2026

About LON:IDHC

Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron emission tomography - computed tomography (PET-CT), MRI, computed tomography (CT), mammography, ultrasound, X-Ray, electromyography, electroencephalog... [Read more]

Sector Healthcare
Founded 1979
Employees 6,309
Stock Exchange London Stock Exchange
Ticker Symbol IDHC
Full Company Profile

Financial Performance

In 2024, LON:IDHC's revenue was 5.72 billion, an increase of 38.74% compared to the previous year's 4.12 billion. Earnings were 1.08 billion, an increase of 111.14%.

Financial numbers in EGP Financial Statements

News

There is no news available yet.